“We’re starting with a focus on improving outcomes for transplant patients, and are making exciting progress scientifically here in Oxford. With great investors onboard, a wonderful team coming together, and an international network of transplant / clinical partners – we are well on our way to developing life-saving medicines for one of the toughest healthcare challenges of our time” said Ochre Bio.
We are thrilled to announce that BIOS was shortlisted for the “Best Innovation in Pharma” in this year’s CogX Awards.
The CogX Awards are the most exciting celebration of innovation and transformational opportunities in the world – a time to give the companies and individuals making a difference a platform.
This year, award categories are spread across six themes: Recognising Leadership, Best AI Product, Best Innovation, Outstanding Achievements & Research Contributions, Best Climate Innovation and Global Goals – with more than 60 individual categories covering verticals from AI to Global Leadership, Financial Services to Climate Change, and from GenZ to Covid-19 Response.
“BIOS is translating our body’s neural code to treat a wide range of chronic diseases. When we can speak the body’s neural language, we’ll be able to innovate fast to react to future health crises.”